Upcoming E&T Webinar: Collaboration Series – CAPhO Conference 2023 Highlights

Wednesday 22nd November 2023 at 19:00 – 20:00 GMT – Click HERE to register

The BOPA Education and Training Subcommittee would like to invite you to the next series of three-part collaboration with Canadian Association of Pharmacy in Oncology (CAPhO) and  Clinical Oncology Society of Australia – Clinical Pharmacists Group (COSA CPG) on the highlights of CAPhO’s 2023 Conference.

 

The webinar is hosted by CAPhO and co-chaired by representatives from COSA and BOPA:

The webinar will showcase the highlights of CAPhO’s 2023 Conference a spotlight on CAPhO23’s Poster Award recipients.

The webinar will feature presentations from the following CAPhO23 Poster Award recipients:

    • Christine Peragine: Systematic Review to Evaluate Impact of Melatonin Supplementation on Efficacy of Oxidizing Cytotoxic Anti-Cancer Therapy
    • Mova Leung: Partnering with Local Community Pharmacies to Improve Care of Patients on Oral Anti-Cancer Drugs: Feasible or Not
    • Ivan Tyono: Resource Impact of Administration of Non-Publicly Funded Drugs at a Tertiary Care Centre

 

This webinar is FREE for all BOPA/COSA/CAPhO members and associates.

Register for your free place now via the link at the top of the page.
CAPhO members to register please click here.
COSA CPG members to register please click here.
Click here to join BOPA

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article